Figure 5.
- ID
- ZDB-IMAGE-260723-49
- Publication
- Liu et al., 2026 - TMEM187 is a novel modulator in the regulation of erythropoiesis
- All Figures
- Figures for Liu et al., 2026
|
Figure 5.
Interference with TMEM187 expression in human primary CD34+ HSCs enhances erythroid differentiation. (A) Workflow with CD34+ HSCs. CD34+ HSCs were isolated from peripheral blood mononuclear cells (PBMCs), transfected every other day for 4 times, with either control (vector) or shTMEM187 plasmid during the flow frame, and followed by induction with erythropoietin (EPO, 1 U/mL). Cells were collected daily for analysis. (B-C) TMEM187 expression (top) and color change of the cell pellets (bottom) (B), and hemoglobin expression, detected by western blotting, in the induction course (C). (D) TMEM187 knockdown in CD34+ HSCs by shRNA. (E-G) Effects of TMEM187 on expression of FECH, HBA, and HBB (E) and iron metabolism-related genes (F) in the differentiation course of CD34+ HSCs, detected by western blotting, and quantified (G). dpi, days post induction. Ponceau S stains were used as internal controls in each figure. t test was used for significance. ∗P < .05; ∗∗P < .01. (H) Effects of TMEM187 on hemoglobin, detected by o-dianisidine staining in CD34+ cells after 2-day induction by EPO addition.